174 related articles for article (PubMed ID: 6267939)
1. A case of lead intoxication: clinical and biochemical studies.
Miwa S; Ishida Y; Takegawa S; Urata G; Toyoda T
Am J Hematol; 1981; 11(1):99-105. PubMed ID: 6267939
[TBL] [Abstract][Full Text] [Related]
2. Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.
Valentine WN; Paglia DE; Fink K; Madokoro G
J Clin Invest; 1976 Oct; 58(4):926-32. PubMed ID: 965496
[TBL] [Abstract][Full Text] [Related]
3. A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.
Fujii H
Arch Toxicol; 1979 Oct; 43(1):59-64. PubMed ID: 231420
[TBL] [Abstract][Full Text] [Related]
4. [Hemolytic anemia caused by pyrimidine 5'-nucleotidase (P5N) deficiency 15 years later. Apropos of 2 new cases of hereditary deficit and another one of lead poisoning].
de la Serna FJ; Gilsanz F; Ricard P; Urrutia A
Med Clin (Barc); 1989 Oct; 93(10):380-2. PubMed ID: 2558262
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte-oxidized glutathione transport in pyrimidine 5'-nucleotidase deficiency.
Kondo T; Ohtsuka Y; Shimada M; Kawakami Y; Hiyoshi Y; Tsuji Y; Fujii H; Miwa S
Am J Hematol; 1987 Sep; 26(1):37-45. PubMed ID: 2888306
[TBL] [Abstract][Full Text] [Related]
6. A case of hemolytic anemia due to erythrocyte pyrimidine 5'-nucleotidase deficiency.
Ozsoylu S; Gurgey A
Acta Haematol; 1981; 66(1):56-8. PubMed ID: 6270945
[TBL] [Abstract][Full Text] [Related]
7. Pyrimidine 5'-nucleotidase deficiency: studies of five cases in two Japanese families.
Ishida Y; Fujii H; Miwa S
Hemoglobin; 1980; 4(5-6):683-91. PubMed ID: 6254920
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.
Kim Y; Yoo CI; Lee CR; Lee JH; Lee H; Kim SR; Chang SH; Lee WJ; Hwang CH; Lee YH
Ind Health; 2002 Jan; 40(1):23-7. PubMed ID: 11926511
[TBL] [Abstract][Full Text] [Related]
9. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
[TBL] [Abstract][Full Text] [Related]
10. Pyrimidine 5'nucleotidase and several other red cell enzyme activities in beta-thalassaemia trait.
Vives Corrons JL; Pujades MA; Aguilar i Bascompte JL; Jou JM; Rozman C; Ester A
Br J Haematol; 1984 Mar; 56(3):483-94. PubMed ID: 6320862
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte disorders of purine and pyrimidine metabolism.
Valentine WN; Paglia DE
Hemoglobin; 1980; 4(5-6):669-81. PubMed ID: 6254919
[TBL] [Abstract][Full Text] [Related]
12. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Lachant NA; Zerez CR; Tanaka KR
Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
[TBL] [Abstract][Full Text] [Related]
13. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
Ichiba M; Tomokuni K
Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
[TBL] [Abstract][Full Text] [Related]
14. Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides.
Paglia DE; Valentine WN; Fink K
J Clin Invest; 1977 Dec; 60(6):1362-6. PubMed ID: 915002
[TBL] [Abstract][Full Text] [Related]
15. Additional data from two kindreds with genetically induced deficiencies of erythrocyte pyrimidine nucleotidase.
Paglia DE; Fink K; Valentine WN
Acta Haematol; 1980; 63(5):262-7. PubMed ID: 6251690
[TBL] [Abstract][Full Text] [Related]
16. Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5'-nucleotidase.
Rosa R; Rochant H; Dreyfus B; Valentin C; Rosa J
Hum Genet; 1977 Sep; 38(2):209-15. PubMed ID: 908567
[TBL] [Abstract][Full Text] [Related]
17. Effects of low-level lead exposure on pyrimidine 5'-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5'-nucleotidase in the pathogenesis of lead-induced anemia.
Paglia DE; Valentine WN; Dahlgren JG
J Clin Invest; 1975 Nov; 56(5):1164-9. PubMed ID: 1184742
[TBL] [Abstract][Full Text] [Related]
18. Hereditary hemolytic anemia with erythrocyte pyrimidine 5'-nucleotidase deficiency in Spain. Clinical, biological and familial studies.
Vives-Corrons JL; Montserrat-Costa E; Rozman C
Hum Genet; 1976 Dec; 34(3):285-92. PubMed ID: 187542
[TBL] [Abstract][Full Text] [Related]
19. [Reviews on biochemical markers of lead exposure with special emphasis on heme and nucleotide metabolisms].
Sakai T
Sangyo Eiseigaku Zasshi; 1995 Mar; 37(2):99-112. PubMed ID: 7749999
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inhibition of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase by lead.
Tomokuni K; Ichiba M
Toxicol Lett; 1988 Feb; 40(2):159-63. PubMed ID: 2829393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
